Nilonib (Nilotinib), generic Tasigna is a prescriptin medicine to treat a type of blood cancer called Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in adults and children who are at least 1 year age or older.
Nilonib manufactured by Drug International Pharma Ltd. in Bangladesh.
Nilotinib should be taken orally twice daily at approximately 12 hours intervals and should be taken on an empty stomach. No food should be eaten for at least 2 hours before the dose is taken and no food should be eaten for at least 1 hour after the dose is taken. Advise patients to swallow the capsules whole with water.
First of all, we’re licensed online pharmacy service provider. We supply most kind of generic prescription medicine globally. We’ve dealings directly with manufacturing pharma company or with their authorized agent. Therefore, here is no doubt to get original Nilonib (Nilotinib) by us. And also, you can check the security code that provided by manufacturing company whether it’s genuine or not. If you feel any issue or doubt, please inform us immediately.
Medicine For World (MFW) is supplying lifesaving prescription medicine worldwide since 2015. We’ve very good reputation as an online medicine supplying service. BBC World News reported about our online medicine service on their program. We assist patient in getting required medicine against valid prescription and other documents as required by the laws of jurisdiction in which they’re present. We consult and facilitate patients, hospitals, clinicians and researchers in accessing products through reliable sources, which are not available or approved in their home country. Also Registered doctors and patients recommend our service to help other patients around the world. Our lots of clients/ patients encourage us by giving their valuable feedback and referring about our service to others. So, we can assure that clients/ patients will get the Nilonib (Nilotinib) without no hassle in-sha-Allah. If you feel any issue or doubt, please inform us immediately.